Metformin: It's the First Choice
David Nathan, MD, Professor at Harvard Medical School, and Director of the Diabetes Center at Massachusetts General Hospital, shares why metformin remains the best first-line therapy for type 2 diabetes. To learn more, visit and subscribe to the NIDDK Diabetes Discoveries & Practice blog: https://www.niddk.nih.gov/health-info...

▶︎
Metformin and Vitamin B12 Deficiency

▶︎
Metformin & DPPOS - 15-year results

▶︎
Addressing Gaps, Challenges, and Opportunities: Day 1

▶︎
Healthy Eating with Diabetes

▶︎
XL Thermosafe Packaging Demonstration

▶︎
Diabetes and Kidney Disease

▶︎
NIDDK-CR Data Science and Meet the Expert Webinar Series: Advancing Collaborative Data Science

▶︎
Diabetes Care and Older Adults

▶︎
Winter 2025 Director’s Update: A Message from Dr. Rodgers

▶︎
Artificial Intelligence in Precision Medicine for Diabetes and Other Chronic Diseases, Day 1

▶︎
Preventing Type 2 Diabetes

▶︎
Advancing Research and Health for All: NIDDK Supports Research Across America

▶︎
NIDDK-CR Webinar Series: Challenges, Opportunities, and Considerations using EHR and RWD Sources

▶︎
Keeping Kidneys Safe - Know How Medicines Affect the Kidneys

▶︎
STP-300 Packaging Demonstration

▶︎
How to Make Healthy Food Choices at Home

▶︎
What are the links between polycystic ovary syndrome (PCOS) and diabetes?

▶︎
Addressing Gaps, Challenges, and Opportunities: Day 2

▶︎
Neural Networks for Detecting Subtle Epileptogenic Lesions and Supporting Clinical Decision-Making

▶︎
